Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Product revenue, net46.21M99.73%
Development and other revenue385K0.83%
Drug product revenue, net-262K-0.57%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
China109.38M74.03%
Japan15.87M10.74%
United States12.96M8.77%
Europe9.55M6.46%
